22 related articles for article (PubMed ID: 10928081)
1. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas.
Kai M; Arakawa H; Sugimoto Y; Murata Y; Ogawa M; Nakamura Y
Jpn J Cancer Res; 1995 Mar; 86(3):249-51. PubMed ID: 7744694
[TBL] [Abstract][Full Text] [Related]
2. Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma.
Kinoshita H; Yamada H; Ogawa O; Kakehi Y; Osaka M; Nakamura E; Mishina M; Habuchi T; Takahashi R; Sugiyama T
Jpn J Cancer Res; 1995 Sep; 86(9):795-9. PubMed ID: 7591954
[TBL] [Abstract][Full Text] [Related]
3. Two target regions of allelic loss on chromosome 9 in urinary-bladder cancer.
Ohgaki K; Minobe K; Kurose K; Iida A; Habuchi T; Ogawa O; Kubota Y; Akimoto M; Emi M
Jpn J Cancer Res; 1999 Sep; 90(9):957-64. PubMed ID: 10551324
[TBL] [Abstract][Full Text] [Related]
4. Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.
Kis A; Tatár TZ; Gáll T; Boda R; Tar I; Major T; Redl P; Gergely L; Szarka K
Pathol Oncol Res; 2014 Oct; 20(4):923-9. PubMed ID: 24710824
[TBL] [Abstract][Full Text] [Related]
5. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
[TBL] [Abstract][Full Text] [Related]
6. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
[TBL] [Abstract][Full Text] [Related]
7. Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma.
Chaubert P; Gayer R; Zimmermann A; Fontolliet C; Stamm B; Bosman F; Shaw P
Hepatology; 1997 Jun; 25(6):1376-81. PubMed ID: 9185756
[TBL] [Abstract][Full Text] [Related]
8. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
[TBL] [Abstract][Full Text] [Related]
9. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
10. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
[TBL] [Abstract][Full Text] [Related]
11. [Genetic alterations associated with hepatocellular carcinoma].
Boige V; Laurent-Puig P
Gastroenterol Clin Biol; 1997; 21(1):34-44. PubMed ID: 9091389
[No Abstract] [Full Text] [Related]
12. Impact of human genome research on medicine--the initial Taiwan experience.
Tsai SF; Chen PJ
J Formos Med Assoc; 2000 Feb; 99(2):107-15. PubMed ID: 10770024
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
